Editas names Albright CSO

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) hired Charles Albright as CSO. He was VP of genetically defined diseases and genomics at Bristol-Myers Squibb Co. (NYSE:BMY). ...